Background: Vitamin D deficiency is common in older adults and has been linked with frailty and obesity,
Introduction 40
Vitamin D is fat-soluble vitamin mainly obtained from sun exposure of the skin and in lesser amounts 41 from diet and supplements (1-3). It is stored mainly in adipose tissue and muscle and, to a lesser extent, in 42 other tissues (4). Vitamin D deficiency is a public health problem of growing concern (5-7), common in older 43 adults (5, 7, 8) and it has been linked to adverse health outcomes such as falls (9), poorer cognitive function 44 (10) and cancer (11) . 25(OH)D concentrations decrease with age, due to a reduction in cutaneous vitamin D 45 synthesis (12), to the possible decline in the ability of the kidney to synthesize 1,25(OH) 2 D (4).
46
Despite the well-known consequences of vitamin D deficiency in bone health (13), this hormone seems to also have a key-role in skeletal muscle (14), namely influencing its function and performance (14, 15) . Frailty 48 increases with age and its prevalence in the community ranges from 4.0-59.1%, depending on the definition 49 adopted (16). It is associated with an increased risk of adverse health outcomes, such as falls, disability, 50 hospitalization and even mortality (17) . Evidence has shown a link between frailty and vitamin D status, with 51 frailty being associated with lower levels of serum 25(OH)D (18). However, the impact of vitamin D 52 deficiency in frailty status in later life is still unknown.
53
Obesity has also increased appreciably worldwide and older adults are no exception (19) . Several 54 meta-analyses reported a significant association with lower serum 25(OH)D concentrations (20) (21) (22) , although 55 the mechanisms underlying this association are not yet fully understood. Furthermore, obesity has also been 56 positively associated with frailty status in older adults (23, 24) , but it remains to be studied whether frail obese 57 older adults are at higher risk of vitamin D deficiency and if the presence of these conditions could 58 simultaneously lead to worse health outcomes. According to the previously described in literature, obese older 59 adults may be predisposed to vitamin D deficiency, which is in turn associated with worse physical function 60 and frailty (18, 25) . Conversely, frailty may impact the amount of sun exposure and, consequently, predispose 61 to vitamin D deficiency. Even though several studies have evaluated the association of frailty status and obesity 62 on vitamin D levels separately (18, 20, 21) , to our knowledge, literature regarding the study of all three 63 conditions is absent. It will be relevant to know if frail obese older adults are more likely to present low vitamin 64 D levels. Besides body mass index (BMI), other adiposity indicators such as waist circumference (WC), body 65 roundness index (BRI) and body shape index (ABSI) may be used (26, 27) . While previous studies have established a link between several indices and vitamin D status, such as BMI and WC (28, 29) , data regarding 67 BRI and ABSI is lacking. Thus, we hypothesized that these indices may be associated with vitamin D status,
68
as higher values may denote worse vitamin D status.
69
Frailty, obesity and vitamin D deficiency are potentially preventable or treatable. Early interventions 70 in these conditions may lead to an improvement in health status and quality of life during the course of 71 ageing (30). So, it is important to elucidate the association between these conditions to target the individuals 72 at risk. Therefore, the aim of this study is to evaluate the association between serum 25(OH)D concentrations, 73 frailty and obesity, but also to examine if there is an interaction effect between frailty and obesity on 25(OH)D 74 levels. In addition, the association of other adiposity indicators, such as WC, BRI and ABSI, with vitamin D 75 status was also explored.
77

Materials and Methods
78
The study sample included individuals enrolled in the Nutrition UP 65 study, a cross-sectional 79 observational study conducted in Portugal. As described in detail previously (31), a cluster sample of 1500 80 individuals with 65 years or older, representative of the Portuguese older population in terms of age, sex, 81 education and regional area was selected. In each regional area, three or more town councils with >250 82 inhabitants were randomly selected and potential community-dwelling participants were contacted via home 83 approach, telephone or via institutions such as town councils and parish centres. Individuals presenting any 84 condition that precluded the collection of venous blood samples or urine (eg, dementia or urinary incontinence)
85
were not included.
86
Data were gathered between December 2015 and June 2016. A structured questionnaire was applied by 87 interview, conducted by eight trained registered nutritionists and anthropometric data were also collected.
88
From the initial sample, forty-six individuals could not be assessed regarding frailty status (n=43) and body 89 mass index (n=4) due to missing data and were therefore excluded from the present analysis. Additionally,
90
seven older adults were also excluded due to missing data regarding the covariates. were considered frail for this criterion (n=28).
114
Self-reported exhaustion was measured using two items from the Center for Epidemiologic Studies
115
Depression Scale (CES-D) (35). The following two statements were read: "I felt that everything I did was an 116 effort" and "In the last week I could not get going." The exhaustion criterion was considered present if a 117 participant answered "a moderate amount of the time" or "most of the time" to the question: "How often in the 118 last week did you feel this way?". Physical activity, assessed by the short form of the International Physical Activity Questionnaire (36), 120 included information regarding the previous seven days, namely on how many days and how much time the 121 participant spent: walking or hiking (at home or at work, moving from place to place, for recreation or sport), presence of one or two of criteria and frailty as the presence of three or more of the following five criteria:
130
"shrinking": evaluated by self-reported unintentional weight loss (>4.5 kg lost unintentionally in prior year);
131
"weakness": assessed by low HGS adjusted for sex and BMI; "poor endurance and energy": evaluated by self- for inadequacy at levels ranging from 12-<20 ng/mL and having sufficient at levels when 25(OH)D concentrations are ≥20 ng/mL (37). Data concerning 25(OH)D levels in Nutrition UP 65 study was previously 146 described (8, 38) .
148
Adiposity indices 149 BMI was calculated as (weight (kg)/ height 2 (m)), and subjects were classified as underweight for BMI 150 below 18.5 kg/m 2 , as normal weight for BMI between 18.5-24.9 kg/m 2 , as pre-obese for BMI between 151 25.0-29.9 kg/m 2 and as obese for BMI above 30.0 kg/m 2 (39). Underweight individuals were included in the 152 reference group ("normal weight") due to its small number (n=3). WC was categorized according to the risk 153 of metabolic complications as increased (men >94 cm; women >80 cm) and substantially increased (men >102 154 cm; women >88 cm) (40). BRI was calculated based on WC (m) and height (m) (27):
156 ABSI (m 11/6 ·kg -2/3 ) was calculated according to the following formula, based on WC (m), BMI (kg/m 2 ) Table 1 ).
223
Regarding coexistence of frailty and obesity ( Supplementary Table 2 ), approximately 75% of older 224 adults presenting both frailty and obesity were women and nearly 67% were aged over 75 years. More than
225
60% of participants with one at least condition (either frailty or obesity or both) were women (p≤0.001).
226
Individuals presenting only obesity were more likely to be younger (64.9%) and 70.9% of the older adults 227 presenting only frailty were in the oldest category (p<0.001). Median 25(OH)D values decreased across obesity 228 and frailty status and were 17.1 ng/mL for non-obese non-frail individuals, 13.6 ng/mL for obese non-frail 229 individuals, 10.1 ng/mL for non-obese frail individuals and 9.2 ng/mL in individuals presenting both obesity 230 and frailty (p<0.001) ( Supplementary Table 2 ).
231
To evaluate the association between the indices BMI, WC, BRI and ABSI, Spearman correlation 232 coefficients were also calculated. BMI was positively and significantly correlated with WC (ρ=0.748), BRI 233 (ρ=0.842) and negatively correlated with ABSI (ρ=-0.121). However, ABSI correlated positively and 234 significantly with WC (ρ=0.476) and BRI (ρ=0.358) ( Supplementary Table 3 ).
235
Comparisons of median 25(OH)D serum levels between obesity and frailty status groups, are displayed 
253
The association between obesity and frailty status and 25(OH)D quartiles was further investigated 254 through multivariate multinomial regression ( .41 (2.83-6.89)* 2.65 (1.63-4.32)* 1.60 (1.14-2.25 73 (1.19-2.51) 1.51 (1.11-2 .04) 0.98 (0.68-1.39) 1.11 (0.81-1.51) 0.98 (0.67-1.38)
Education level
Without schooling 1.00 1.00 1.00 1.00 1.00 1. 61 (0.42-0.89) 0.48 (0.35-0.66)* 0.59 (0.41-0.84) 0.67 (0.49-0.92) 0.69 (0.49-0 .85 (1.36-5.97) 2.82 (1.29-6.13) 
Skin phenotype
Red-haired with freckles or fair-haired people 1.00 1.00 1.00 1.00 1.00 1.00
Dark-haired or Latin people 1.03 (0.70-1.52) 1.24 (0. 81-1.91) 0.69 (0.48-0.99) 0.76 (0.52-1.12) 0.63 (0.44-0.90) 0.64 (0.44-0.93 
Season of blood collection
Spring/Summer 1.00 1.00 1.00 1.00 1.00 1.00 5.54 (4.02-7.64)* 4.46 (3.08-6.46)* 2.21 (1.64-2.98)* 2.10 (1.50-2.95)* 1.38 (1.02-1.86) 1.48 (1.06-2 .07)
Autumn/Winter
Vitamin D supplementation
No use 1.00 1.00 1.00 1.00 1.00 1.00 0.11 (0.04-0.28)* 0.08 (0.03-0.20)* 0.20 (0.10-0.40)* 0.16 (0.08-0.34)* 0.29 (0.16-0.54)* 0.27 (0.14-0 .49)* 3.14 (1.87-5.27 274 (95% CI: 1.86-5.38) for the third and fourth ABSI quartiles, respectively (P for trend <0.001).
Use of vitamin D supplements
Unknown use or composition
275
In the second quartile of serum 25(OH)D levels, there was also a significant positive association 276 with the third BRI quartile (OR: 2.14; 95% CI: 1.37-3.34) and fourth BRI quartile (OR: 2.51; 95% CI: 277 1.55-4.05), P for trend <0.001. Similarly, the third ABSI quartile was also positively associated with 278 second quartile of serum 25(OH)D levels (OR: 1.99; 95% CI: 1.23-3.21).
279
Additionally, when an interaction effect between frailty status and adiposity indices was tested 280 statistical differences were not found.
281 
286
Waist circumference was further adjusted for height. Bold text indicates a statistically significant difference with a p-value less than 0.05.
287
⁕Missing data in 10 individuals.
288
*p≤0.001
Discussion
290
In this cross-sectional study an inverse association between frailty and obesity with serum 291 25(OH)D concentrations, independently of sex, age, educational level, alcohol consumption, smoking, 292 skin phenotype, vitamin D supplementation, season of blood collection and cognitive function, was 293 found. These results were consistent with findings of several meta-analyses which evaluate the 294 association between each of these conditions with vitamin D deficiency (18, 20, 21) . The interaction 295 between frailty and adiposity indices concerning serum 25(OH)D was further explored but no significant 296 results were found, meaning that frailty and obesity are independently associated with lower serum 297 25(OH)D levels, and the effect of frailty (or obesity) on serum 25(OH)D levels is the same at all levels 298 of obesity (or frailty).
299
When we compared vitamin D levels between frailty and obesity groups we found decreasing 300 25(OH)D concentrations across them. Thus, individuals that were not frail or obese presented higher 301 unadjusted median 25(OH)D serum concentrations than the other study participants. Interestingly, when 302 data were stratified by sex the pattern was very similar in women, however results were not as evident 303 among men. These observations were supported after by the results of logistic regression, which 304 revealed an association between these conditions and lower serum 25(OH)D levels.
305
All adiposity indicators evaluated were inversely associated with 25(OH)D serum 306 concentrations. Regarding BMI, an inverse association between 25(OH)D levels and obesity, but not for 307 pre-obesity was found. Moreover, being at the fourth quartile of BRI was associated with a four-fold 308 increased risk of presenting 25(OH)D levels in the first quartile, and it was more strongly associated 309 than the other studied adiposity indicators. It was also observed that the odds of being in the first quartile 310 of 25(OH)D increased significantly across BRI quartiles.
311
Physiological changes that occur with ageing predispose older adults to lower levels of serum 
345
Body mass index and WC are traditionally chosen as anthropometric indicators of general and 346 abdominal adiposity, respectively. Nevertheless, in the present study, the other adiposity indices 347 evaluated (BRI and ABSI), were positively associated with lower vitamin D levels, showing that these 348 may also be used as alternative obesity indicators to identify older adults at risk of low 25(OH)D levels.
349
Despite the lack of positive correlation between ABSI and BMI, our study also demonstrated the link 350 between these indices and lower vitamin D levels, which reinforces their utility.
351
The present study has some limitations. Firstly, this was a cross-sectional study, therefore the 352 possibility of reverse causation should not be excluded. Secondly, although we have adjusted for 353 multiple covariates, the possible occurrence of residual confounding cannot be ruled out. Thirdly, serum 354 25(OH)D concentrations were measured using electrochemiluminescence immunoassay, when liquid 355 chromatography-tandem mass spectrometry is considered the golden standard, which can introduce 356 variability in the results (58). And, lastly, participants´ sun exposure levels were not assessed.
357
In contrast, some strengths can also be pointed out. To our knowledge, this is the first study to 358 explore the association of BRI and ABSI with serum 25(OH)D levels and to elucidate the impact of both 359 obesity and frailty status on 25(OH)D serum levels. Moreover, for all the studied sample, vitamin D was 360 dosed with the same method, the same equipment and in the same laboratory. The very low serum 361 25(OH)D levels in our sample, with only 30% of the sample presenting adequate 25(OH)D serum 362 concentrations, allowed to study this association.
363
In summary, present results show that besides BMI and WC, other measures of adiposity such 364 as BRI and ABSI are inversely associated with 25(OH)D serum concentrations. As discussed above,
365 several studies reported conflicting results, however present results reinforce the positive relationship 366 between vitamin D deficiency and both frailty and obesity. Plus, they emphasize the need to target obese 367 and frail elderly people and monitoring their serum vitamin D levels with special care. However,
368
longitudinal studies are necessary to fully elucidate these associations.
